iView Therapeutics

Cranbury, NJ · Founded 2015 · Privately Held (backing)

Developer of topical drugs designed for applications in ophthalmology, dermatology, and otolaryngology. iView Therapeutics is based in Cranbury, NJ and was founded in 2015. It was valued at $107 million at its later-stage round in Jun 2025, the last priced event on record. It has raised $39.2 million across 2 recorded rounds; the latest was a $9.2 million early-stage round in May 2024.

PMV mark · valuation
$107.4M
Oct 2026
Priced at
its later-stage round
Jun 2025
Total raised
$39.2M
Last round
Early Stage VC
May 2024

Who backs iView Therapeutics?

16 investors
InvestorType
Cowin CapitalVenture capital
Proxima Ventures (China)Venture capital
BioAdvance Capital (Conshohocken)Venture capital
Alpha Bioventure—
Chongqing Dian Petrochemical Medical Fund Management—
Haitian International—
Haitian International Holdings—
Hangzhou Jiurun Investment—
Jiufeng Capital—
Jun Yuan Capital—
+ 6 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

iView Therapeutics investors

16 investors are on record for iView Therapeutics, including Cowin Capital, Proxima Ventures (China), BioAdvance Capital (Conshohocken) and Alpha Bioventure. The early-stage round in May 2024 drew 5 investors.

Free account
More of iView Therapeutics with a free account
  • ·The complete investor list: 16 names
  • ·Watch iView Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 16 firms already write checks for companies like iView Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View